AJP - Cell Physiology, Vol 259, Issue 5 C697-C708, Copyright © 1990 by American Physiological Society

ARTICLES

Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators

F. Snyder
Medical Sciences Division, Oak Ridge Associated Universities, Tennessee 37831-0117.

Platelet-activating factor (PAF or 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is the most potent lipid mediator yet discovered. It is known to stimulate a wide span of biological responses ranging from aggregation and degranulation of platelets and neutrophils to a variety of cellular effects involving the stimulation of chemotaxis; chemokinesis; superoxide formation; protein phosphorylation; activation of protein kinase C, arachidonic acid, and phosphoinositide metabolites; glycogenolysis; and tumor necrosis factor production. Obviously, with such a diversity of biological activities, it is not surprising that PAF has been considered to be a key component in numerous diseases related to hypersensitivity and inflammatory responses. Evidence has also been presented for the role of PAF in physiological processes, particularly those involving reproduction and fetal development. Furthermore, because of its potent hypotensive action, PAF has been implicated as a contributing factor in blood pressure regulation. PAF is produced by two independent enzymatic pathways. The remodeling route involves the structural modification of a membrane lipid (1-alkyl-2-acyl-sn-glycero-3-phosphocholine) by replacement of the acyl moiety with an acetate group. An alternate route is the de novo synthesis of PAF from an O-alkyl analogue of a lysophosphatidic acid that requires a reaction sequence of acetylation, dephosphorylation, and phosphocholine addition steps. Hypersensitivity and other pathophysiological reactions are thought to be caused by activation of the remodeling pathway, whereas the de novo route is believed to be the source of endogenous levels of PAF required for physiological functions. Inactivation of PAF occurs when the acetate group is hydrolyzed by an acetylhydrolase that is present in both extra- and intracellular compartments, although the catalytic activity of the two forms of acetylhydrolase are identical, some of their properties differ. The control of PAF metabolism is very complex, but acetylhydrolase, Ca2+, phosphorylation/dephosphorylation of enzymes, and fatty acids (especially polyunsaturates) appear to be important regulatory factors. Specific PAF receptors have clearly been demonstrated on several different types of cells, and although the mechanism of PAF actions is poorly understood, it appears that the PAF/receptor-induced responses are closely associated with the signal transduction process; both G proteins and adenyl cyclase appear to be involved. Because significant quantities of PAF are often retained within certain cells, the possibility of PAF serving as an intracellular mediator has also been proposed.

This article has been cited by other articles:

				T. M. Osborn, C. Dahlgren, J. H. Hartwig, and T. P. Stossel Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1323 - C1330. [Abstract] [Full Text] [PDF]

				J. L. Wallace and L. Ma Inflammatory Mediators in Gastrointestinal Defense and Injury Experimental Biology and Medicine, December 1, 2001; 226(11): 1003 - 1015. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				H. Sawai, N. Domae, N. Nagan, and Y. A. Hannun Function of the Cloned Putative Neutral Sphingomyelinase as Lyso-platelet Activating Factor-Phospholipase C J. Biol. Chem., December 31, 1999; 274(53): 38131 - 38139. [Abstract] [Full Text] [PDF]

				B. D. Flickinger and M. S. Olson Localization of the Platelet-Activating Factor Receptor to Rat Pancreatic Microvascular Endothelial Cells Am. J. Pathol., May 1, 1999; 154(5): 1353 - 1358. [Abstract] [Full Text] [PDF]

				X W Qu, R A Rozenfeld, W Huang, G B Bulkley, and W Hsueh The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat Gut, February 1, 1999; 44(2): 203 - 211. [Abstract] [Full Text] [PDF]

				S. Abu-Raya, E. Bloch-Shilderman, E. Shohami, V. Trembovler, Y. Shai, J. Weidenfeld, S. Yedgar, Y. Gutman, and P. Lazarovici Pardaxin, a New Pharmacological Tool to Stimulate the Arachidonic Acid Cascade in PC12 Cells J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 889 - 896. [Abstract] [Full Text]

				S. Pickelmann, D. Nolte, R. Leiderer, E. Schutze, and K. Messmer Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross-linked Hb Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H361 - H368. [Abstract] [Full Text] [PDF]

				Y. Cao, D. M. Stafforini, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott Expression of Plasma Platelet-activating Factor Acetylhydrolase Is Transcriptionally Regulated by Mediators of Inflammation J. Biol. Chem., February 13, 1998; 273(7): 4012 - 4020. [Abstract] [Full Text] [PDF]

				D. Xia and D. Samols Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia PNAS, March 18, 1997; 94(6): 2575 - 2580. [Abstract] [Full Text] [PDF]

				S. A. Carlson, T. K. Chatterjee, and R. A. Fisher The Third Intracellular Domain of the Platelet-activating Factor Receptor Is a Critical Determinant in Receptor Coupling to Phosphoinositide Phospholipase C-activating G Proteins. STUDIES USING INTRACELLULAR DOMAIN MINIGENES AND RECEPTOR CHIMERAS J. Biol. Chem., September 20, 1996; 271(38): 23146 - 23153. [Abstract] [Full Text] [PDF]

				V. Lukashova, C. Asselin, J. J. Krolewski, M. Rola-Pleszczynski, and J. Stankova G-protein-independent Activation of Tyk2 by the Platelet-activating Factor Receptor J. Biol. Chem., June 22, 2001; 276(26): 24113 - 24121. [Abstract] [Full Text] [PDF]